Can Preoperative Mapping with Functional MRI Reduce Morbidity in Brain Tumor Resection? A Systematic Review and

Licia P Luna1, Farzaneh Ghazi Sherbaf1, Haris I Sair1

  • 1From the Russell H. Morgan Department of Radiology and Radiological Science, Division of Neuroradiology, Johns Hopkins Hospital, 600 N Wolfe St, Phipps B100F, Baltimore, MD 21287 (L.P.L., F.G.S., H.I.S.); Department of Neurosurgery, Johns Hopkins University, Baltimore, Md (D.M.); Department of Radiology, Hospital Geral de Fortaleza, Fortaleza, Brazil (I.B.O.); and Medical Sciences Post-Graduation Program, Department of Internal Medicine, School of Medicine, Federal University of Ceará, Fortaleza, Brazil (C.A.K.).

Radiology
|June 1, 2021
PubMed

Insights

Preoperative functional MRI (fMRI) significantly reduces the risk of functional decline and improves outcomes for brain tumor surgery. This neuroimaging technique lowers postsurgical adverse event rates compared to standard procedures.

Area of Science:

  • Neurosurgery
  • Neuroradiology
  • Medical Imaging

Background:

  • Preoperative functional MRI (fMRI) is a technique for localizing critical brain structures and tumors.
  • Its utility in surgical planning and impact on neurological outcomes remain under investigation.
  • Assessing fMRI's role in reducing postoperative morbidity in brain tumor patients is crucial.

Purpose of the Study:

  • To evaluate the overall postoperative morbidity in brain tumor patients.
  • Compare outcomes between surgeries using preoperative fMRI and those without or with standard neuronavigation.

Main Methods:

  • Systematic review and meta-analysis of studies from 1946 to June 2020.
  • Inclusion criteria: brain tumor patients, preoperative fMRI, tumor resection using functional neuroimaging, and reported postoperative measures.
  • Random-effects model used to compute pooled estimates for adverse event rates and effect sizes.

Main Results:

  • Sixty-eight studies (3280 participants) were included.
  • fMRI mapping was associated with a lower likelihood of functional deterioration (OR, 0.25; P < .001) and higher Karnofsky scores (Hedges g, 0.66; P = .004).
  • Adverse event rate for craniotomies with fMRI was 11%, compared to 21.0% without fMRI.

Conclusions:

  • Preoperative fMRI planning for brain tumor resection appears to reduce postsurgical morbidity.
  • Benefits are enhanced when fMRI is combined with advanced techniques like diffusion-tensor imaging or intraoperative MRI.
  • fMRI is a valuable tool for improving patient outcomes in neurosurgical oncology.

Related Concept Videos